Game da Mu

Bayanin Kamfanin

An kafa shi a birnin Beijing a watan Satumba na shekarar 1995, kamfanin Beijing Beier Bioengineering Co., Ltd. babban kamfani ne na fasahar kere-kere a kasar Sin wanda ya kware wajen kera da samar da na'urorin gano kwayoyin cutar in vitro.

Ƙirƙirar fasaha koyaushe ita ce ƙarfin farko don ci gaban kamfanin.Bayan fiye da shekaru 20 na bincike da ci gaba mai zaman kanta, Beier ya gina nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in aikin, gami da magnetic barbashi chemiluminescence diagnostic reagent, ELISA diagnostic reagent dandamali, colloidal zinariya POCT m ganewar asali reagent, PCR kwayoyin ganewar asali reagent, biochemical bincike reagent, da kayan aiki masana'antu.Idan an kafa cikakken samfurin layin da ke rufe cututtukan cututtukan numfashi, kulawar haihuwa da haihuwa, hepatitis, cutar Epstein-Barr, autoantibodies, alamun ƙari, aikin thyroid, fibrosis hanta, hauhawar jini, da sauran filayen.

Amfaninmu

Tun lokacin da aka kafa shi, kudaden shiga na tallace-tallace ya ci gaba da girma, kuma sannu a hankali ya zama ɗaya daga cikin kamfanoni na cikin gida na farko a cikin in vitro a China.

kamar (1)

Dangantakar Hadin Kai

A matsayin daya daga cikin kamfanonin da ke da cikakken kewayon kayayyakin rigakafin rigakafi a cikin masana'antar, Beier ya cimma dangantakar hadin gwiwa ta dogon lokaci tare da asibitoci sama da 10,000 da abokan hulda sama da 2,000 a ciki da wajen kasar Sin.

kamar (3)

Babban Kasuwa Raba

Daga cikin su, na'urorin gano cututtukan cututtukan numfashi, kwayar cutar Epstein-Barr da kula da haihuwa da haihuwa sune samfuran farko da aka amince da su don tallatawa a kasar Sin, suna matsayi na uku a cikin manyan kasuwannin cikin gida kuma sun keta matsayin ketare na kayayyakin da ake shigo da su a kasar Sin.

kamar (4)

Ci gaba da kyau

Beier yana ɗaukar lafiyar ɗan adam a matsayin aikin kansa kuma yana mai da hankali kan bincika sabbin wuraren ganowa.A halin yanzu, Beier ya ƙirƙiri tsarin haɓaka ƙungiya da haɓaka haɓakar dandamali na samfuran.

Tarihin Kamfanin

  • 1995
  • 1998
  • 1999
  • 2001
  • 2005
  • 2006
  • 2007
  • 2008
  • 2009
  • 2010
  • 2011
  • 2012
  • 2013
  • 2014
  • 2015
  • 2016
  • 2017
  • 2018
  • 2019
  • 2020
  • 2021
  • 2022
  • 1995
    • A 1995, kafa a matsayin high-tech sha'anin.
    1995
  • 1998
    • A cikin 1998, "Human Chorionic Gonadotropin gwajin kit (Colloidal Gold)" an amince da Ma'aikatar Lafiya.
    1998
  • 1999
    • A cikin 1999, an ɗauki Shirin 863 na ƙasa "Bincike akan Specific Gene Diagnostic Reagents for Pathogenic Microorganisms" don haɓaka kayan rigakafin Helicobacter pylori na ELISA.
    1999
  • 2001
    • A shekara ta 2001, kamfani na farko a kasar Sin ya sami rajistar "Anti-Helicobacter pylori antibody ELISA kit".
    2001
  • 2005
    • A 2005, GMP bokan.
    2005
  • 2006
    • A cikin 2006, kamfani na farko a China don samun rajista don "Human Cytomegalovirus IgM Antibody ELISA Kit".
    2006
  • 2007
    • A cikin 2007, kamfani na farko a China don samun rajista don "EB VCA antibody (IgA) ELISA kit".
    2007
  • 2008
    • A cikin 2008, kamfani na farko a kasar Sin don samun rajistar "kayayyakin 10 na TORCH ELISA da abubuwa 4 na gwajin sauri na TORCH-IgM".
    2008
  • 2009
    • A shekara ta 2009, kamfani na farko a kasar Sin ya sami rajistar "Kitin Gwajin Kwayar cutar Hepatitis D".
    2009
  • 2010
    • A cikin 2010, kamfani na farko a China don samun rajistar "Enterovirus 71 IgM / IgG ELISA kit".Tabbataccen GMP na lokaci na biyu.
    2010
  • 2011
    • A cikin 2011, aikin "Giant Cell Recombinant Antigen" ya sami lambar yabo ta uku na lambar yabo ta Kimiyya da Fasaha.
    2011
  • 2012
    • A cikin 2012, kamfani na farko da ya sami rajista na "EB virus series test kit (Enzyme-linked Immunoassay)" don ganewar cutar dysentery monocyte.
    2012
  • 2013
    • A cikin 2013, kamfani na farko da ya sami rajista na Coxsackie Group B virus IgM / IgG ELISA kit don gano ƙwayar cutar myocarditis.
    2013
  • 2014
    • A cikin 2014, an ƙaddamar da haɓaka na'urorin gano ƙwayoyin cuta na numfashi a cikin babban aikin bincike na shekaru goma sha biyu na ƙasa "AIDS da Manyan Cututtuka masu Yaduwa".Shi ne kamfani na farko a kasar Sin da ya sami rajistar na'urorin gwajin cututtukan numfashi guda 12 na IgM / IgG.
    2014
  • 2015
    • A cikin 2015, kamfani na farko a kasar Sin don samun rajistar "kayan gwajin streptococcus pneumoniae antigen" kuma ya kammala takardar shaidar GMP na uku.
    2015
  • 2016
    • A cikin 2016, "EV71 virus IgM test kit" ya lashe lambar yabo ta uku na Ci gaban Kimiyya da Fasaha ta Beijing."Bincike da haɓakawa da aikace-aikacen jerin ƙwayoyin ƙwayoyin cuta na ƙwayoyin cuta da na'urori masu bincike da fasaha" sun sami lambar yabo ta farko na Ci gaban Kimiyya da Fasaha na Jiangsu.An ƙaddamar da ƙimar takaddun shaida na ISO13485.
    2016
  • 2017
    • •A cikin 2017, gudanar da ci gaban bincike reagents ga kwatsam m cututtuka a cikin National 13th shekaru biyar key Project "Rigakafin da Sarrafa manyan cututtuka irin su AIDS da Viral Hepatitis".
    2017
  • 2018
    • A cikin 2018, an sami rajistar samfur TORCH 10 (Magneto barbashi Chemiluminescence).
    2018
  • 2019
    • •A cikin 2019, kamfani na gida na farko da ya sami rajistar cututtukan cututtukan numfashi (Magnetic particle chemiluminescence).• A cikin 2019, an sami rajistar samfuran EB virus (Magnetic particle chemiluminescence) jerin samfuran.
    2019
  • 2020
    • A cikin 2020, an gudanar da aikin gaggawa na Hukumar Kimiyya da Fasaha ta gundumar Beijing "R & D na Sabon Coronavirus (2019-nCoV) Antibody Rapid Test Cassette".Gwajin saurin Antigen na COVID-19 ya sami rajistar CE, wanda ya dace da cancantar samun damar EU.An sami rajistar samfuran kula da inganci don abubuwan eugenic 10.
    2020
  • 2021
    • A cikin 2021, kamfani na farko a China don samun rajista don abubuwa 9 na samfuran sarrafa ingancin rigakafin IgM don cututtukan cututtukan numfashi.Gwajin saurin Antigen na COVID-19 ya sami takardar shedar CE don gwajin kai daga PCBC.
    2021
  • 2022
    • •A cikin 2022, gwajin gaggawa na Antigen na COVID-19 ya shiga cikin jerin gama gari na EU na nau'in A.
    2022